Vital Organs Support Systems and Medical Bionics Market Overview
The Organ Support System includes artificial organs which are designed to perform the function of natural human organs. They are used as a substitute for lost body organs, replacement of the damaged organ, and support to the existing organs. Medical bionics is the study of mechanical systems that replicate parts of living organisms. Owing to various benefits such as cost-effective alternatives for curing multiple diseases, reduced risk of organ rejection, and reducing dependency on human donors. These benefits are projected to enhance the growth of vital organ support systems and the medical bionics market.
The other important factors such as the increasing number of patients suffering from chronic diseases and technological advancements in medical devices boost the growth of the market. Furthermore, High demand has been witnessed from patients for organ transplantation surgery, but the number of donors available to fulfil this demand is limited. As a result, a wider supply-demand gap, which lifts the growth of the global vital organs support systems and medical bionics market.
On the other hand, the high cost of treatment and strict approval process hampering the market development. Also, increasing technological advancements in the artificial organ sector are predictable to provide new opportunities for the market during the forecast period.
Vital Organs Support Systems and Medical Bionics Market Segment Overview
Based on end-user, the hospital segment accounted for the largest segmental revenue of the market in 2020. This is attributed to the various support departments, such as MRI suites and ICUs, that are available. Additionally, every day in the United States, 21 people die waiting for an organ and more than 120,048 men, women, and children await life-saving organ transplants.
Vital Organs Support Systems and Medical Bionics Market Regional Overview
North America dominated the vital organs support systems and medical bionics market in the year 2020. The factors such as growth in the geriatric population and lack of organs donor are driving the growth of the target market in the region. The market of the Asia Pacific is projected to grow at the fastest rate owing to the rising incidence of chronic disorders, increase in R&D expenditure, and government & private sector initiatives to increase awareness about artificial organs transplantation.
Vital Organs Support Systems and Medical Bionics Market Competitor overview
Major players operating in the industry are focusing on R&D to manufacture safer products for patient compliance and safety. Companies are engrossed in collaborations, mergers & acquisitions to improve the market share.
Vital Organs Support Systems and Medical Bionics Market, Key Players
Vital Organs Support Systems and Medical Bionics Market Segmentation
Vital Organs Support Systems and Medical Bionics Market, By Vital Organs Support Systems
The Organ Support System includes artificial organs which are designed to perform the function of natural human organs. They are used as a substitute for lost body organs, replacement of the damaged organ, and support to the existing organs. Medical bionics is the study of mechanical systems that replicate parts of living organisms. Owing to various benefits such as cost-effective alternatives for curing multiple diseases, reduced risk of organ rejection, and reducing dependency on human donors. These benefits are projected to enhance the growth of vital organ support systems and the medical bionics market.
The other important factors such as the increasing number of patients suffering from chronic diseases and technological advancements in medical devices boost the growth of the market. Furthermore, High demand has been witnessed from patients for organ transplantation surgery, but the number of donors available to fulfil this demand is limited. As a result, a wider supply-demand gap, which lifts the growth of the global vital organs support systems and medical bionics market.
On the other hand, the high cost of treatment and strict approval process hampering the market development. Also, increasing technological advancements in the artificial organ sector are predictable to provide new opportunities for the market during the forecast period.
Vital Organs Support Systems and Medical Bionics Market Segment Overview
Based on end-user, the hospital segment accounted for the largest segmental revenue of the market in 2020. This is attributed to the various support departments, such as MRI suites and ICUs, that are available. Additionally, every day in the United States, 21 people die waiting for an organ and more than 120,048 men, women, and children await life-saving organ transplants.
Vital Organs Support Systems and Medical Bionics Market Regional Overview
North America dominated the vital organs support systems and medical bionics market in the year 2020. The factors such as growth in the geriatric population and lack of organs donor are driving the growth of the target market in the region. The market of the Asia Pacific is projected to grow at the fastest rate owing to the rising incidence of chronic disorders, increase in R&D expenditure, and government & private sector initiatives to increase awareness about artificial organs transplantation.
Vital Organs Support Systems and Medical Bionics Market Competitor overview
Major players operating in the industry are focusing on R&D to manufacture safer products for patient compliance and safety. Companies are engrossed in collaborations, mergers & acquisitions to improve the market share.
- In January 2020, Medtronic plc announced it has received CE (Conformité Européenne) Mark for its Cobalt and Crome portfolio of implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D).
- In March 2019, Baxter International Inc., is committed to advancing surgical innovation and announced it has completed its acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is the first and only stand-alone recombinant thrombin and PREVELEAK Surgical Sealant is used in vascular reconstruction.
- In October 2018, Cochlear Limited announced the next phase in its long-term research and development program towards a totally implantable cochlear implant, with the start of a further clinical feasibility study. The development of totally implantable cochlear implant technology is complex, and a commercially available product is not expected for years; however, it remains a long-term development goal for Cochlear.
Vital Organs Support Systems and Medical Bionics Market, Key Players
- Baxter International Inc.
- Cochlear Ltd
- Edwards Lifesciences Corporation
- Heartware International Inc
- Abbott Laboratories
- Abiomed, Inc.
- Asahi Kasei Corporation
- Boston Scientific Corporation,
- Jarvik Heart, Inc.
- Medtronic Plc.
- Össur Americas, Inc.
- Second Sight Medical Products, Inc.
- SynCardia Systems LLC.
- Getinge AB
- LivaNova PLC
- Fresenius Medical Care AG & Co. KGaA
- Heartware International Inc.
- BiVACOR
Vital Organs Support Systems and Medical Bionics Market Segmentation
Vital Organs Support Systems and Medical Bionics Market, By Vital Organs Support Systems
- Artificial Heart
- Artificial Kidney
- Artificial Pancreas
- Artificial Urinary Bladder
- Artificial Lungs
- Artificial Liver
- Bionic Eye
- Ear Bionics
- Cochlear Implants
- Bone Anchored Hearing Systems
- Auditory Brainstem Implants
- Orthopedic Bionics
- Upper Limb
- Lower Limb
- Exoskeleton
- Electrical Bone Growth Stimulators
- Cardiac Bionics
- Pacemaker
- Ventricular Assist Device
- Artificial Heart Valves
- Neural Bionics
- Internal Neurostimulators
- External Neurostimulators
- Hospitals
- Ambulatory Surgical Centers
- Others
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
- 5.2.1. Artificial Heart
- 5.2.2. Artificial Kidney
- 5.2.3. Artificial Pancreas
- 5.2.4. Artificial Urinary Bladder
- 5.2.5. Artificial Lungs
- 5.2.6. Artificial Liver
- 5.3. Market Analysis, Insights and Forecast – By Medical Bionics
- 5.3.1. Bionic Eye
- 5.3.2. Ear Bionics
- 5.3.2.1. Cochlear Implants
- 5.3.2.2. Bone Anchored Hearing Systems
- 5.3.2.3. Auditory Brainstem Implants
- 5.3.3. Orthopedic Bionics
- 5.3.3.1. Upper Limb
- 5.3.3.2. Lower Limb
- 5.3.3.3. Exoskeleton
- 5.3.3.4. Electrical Bone Growth Stimulators
- 5.3.4. Cardiac Bionics
- 5.3.4.1. Pacemaker
- 5.3.4.2. Ventricular Assist Device
- 5.3.4.3. Artificial Heart Valves
- 5.3.5. Neural Bionics
- 5.3.5.1. Internal Neurostimulators
- 5.3.5.2. External Neurostimulators
- 5.4.1. Hospitals
- 5.4.2. Ambulatory Surgical Centers
- 5.4.3. Others
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
- 6.2.1. Artificial Heart
- 6.2.2. Artificial Kidney
- 6.2.3. Artificial Pancreas
- 6.2.4. Artificial Urinary Bladder
- 6.2.5. Artificial Lungs
- 6.2.6. Artificial Liver
- 6.3. Market Analysis, Insights and Forecast – By Medical Bionics
- 6.3.1. Bionic Eye
- 6.3.2. Ear Bionics
- 6.3.2.1. Cochlear Implants
- 6.3.2.2. Bone Anchored Hearing Systems
- 6.3.2.3. Auditory Brainstem Implants
- 6.3.3. Orthopedic Bionics
- 6.3.3.1. Upper Limb
- 6.3.3.2. Lower Limb
- 6.3.3.3. Exoskeleton
- 6.3.3.4. Electrical Bone Growth Stimulators
- 6.3.4. Cardiac Bionics
- 6.3.4.1. Pacemaker
- 6.3.4.2. Ventricular Assist Device
- 6.3.4.3. Artificial Heart Valves
- 6.3.5. Neural Bionics
- 6.3.5.1. Internal Neurostimulators
- 6.3.5.2. External Neurostimulators
- 6.4.1. Hospitals
- 6.4.2. Ambulatory Surgical Centers
- 6.4.3. Others
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
- 7.2.1. Artificial Heart
- 7.2.2. Artificial Kidney
- 7.2.3. Artificial Pancreas
- 7.2.4. Artificial Urinary Bladder
- 7.2.5. Artificial Lungs
- 7.2.6. Artificial Liver
- 7.3. Market Analysis, Insights and Forecast – By Medical Bionics
- 7.3.1. Bionic Eye
- 7.3.2. Ear Bionics
- 7.3.2.1. Cochlear Implants
- 7.3.2.2. Bone Anchored Hearing Systems
- 7.3.2.3. Auditory Brainstem Implants
- 7.3.3. Orthopedic Bionics
- 7.3.3.1. Upper Limb
- 7.3.3.2. Lower Limb
- 7.3.3.3. Exoskeleton
- 7.3.3.4. Electrical Bone Growth Stimulators
- 7.3.4. Cardiac Bionics
- 7.3.4.1. Pacemaker
- 7.3.4.2. Ventricular Assist Device
- 7.3.4.3. Artificial Heart Valves
- 7.3.5. Neural Bionics
- 7.3.5.1. Internal Neurostimulators
- 7.3.5.2. External Neurostimulators
- 7.4.1. Hospitals
- 7.4.2. Ambulatory Surgical Centers
- 7.4.3. Others
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
- 8.2.1. Artificial Heart
- 8.2.2. Artificial Kidney
- 8.2.3. Artificial Pancreas
- 8.2.4. Artificial Urinary Bladder
- 8.2.5. Artificial Lungs
- 8.2.6. Artificial Liver
- 8.3. Market Analysis, Insights and Forecast – By Medical Bionics
- 8.3.1. Bionic Eye
- 8.3.2. Ear Bionics
- 8.3.2.1. Cochlear Implants
- 8.3.2.2. Bone Anchored Hearing Systems
- 8.3.2.3. Auditory Brainstem Implants
- 8.3.3. Orthopedic Bionics
- 8.3.3.1. Upper Limb
- 8.3.3.2. Lower Limb
- 8.3.3.3. Exoskeleton
- 8.3.3.4. Electrical Bone Growth Stimulators
- 8.3.4. Cardiac Bionics
- 8.3.4.1. Pacemaker
- 8.3.4.2. Ventricular Assist Device
- 8.3.4.3. Artificial Heart Valves
- 8.3.5. Neural Bionics
- 8.3.5.1. Internal Neurostimulators
- 8.3.5.2. External Neurostimulators
- 8.4.1. Hospitals
- 8.4.2. Ambulatory Surgical Centers
- 8.4.3. Others
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
- 9.2.1. Artificial Heart
- 9.2.2. Artificial Kidney
- 9.2.3. Artificial Pancreas
- 9.2.4. Artificial Urinary Bladder
- 9.2.5. Artificial Lungs
- 9.2.6. Artificial Liver
- 9.3. Market Analysis, Insights and Forecast – By Medical Bionics
- 9.3.1. Bionic Eye
- 9.3.2. Ear Bionics
- 9.3.2.1. Cochlear Implants
- 9.3.2.2. Bone Anchored Hearing Systems
- 9.3.2.3. Auditory Brainstem Implants
- 9.3.3. Orthopedic Bionics
- 9.3.3.1. Upper Limb
- 9.3.3.2. Lower Limb
- 9.3.3.3. Exoskeleton
- 9.3.3.4. Electrical Bone Growth Stimulators
- 9.3.4. Cardiac Bionics
- 9.3.4.1. Pacemaker
- 9.3.4.2. Ventricular Assist Device
- 9.3.4.3. Artificial Heart Valves
- 9.3.5. Neural Bionics
- 9.3.5.1. Internal Neurostimulators
- 9.3.5.2. External Neurostimulators
- 9.4.1. Hospitals
- 9.4.2. Ambulatory Surgical Centers
- 9.4.3. Others
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa Vital Organs Support Systems and Medical Bionics Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Vital Organs Support Systems
- 10.2.1. Artificial Heart
- 10.2.2. Artificial Kidney
- 10.2.3. Artificial Pancreas
- 10.2.4. Artificial Urinary Bladder
- 10.2.5. Artificial Lungs
- 10.2.6. Artificial Liver
- 10.3. Market Analysis, Insights and Forecast – By Medical Bionics
- 10.3.1. Bionic Eye
- 10.3.2. Ear Bionics
- 10.3.2.1. Cochlear Implants
- 10.3.2.2. Bone Anchored Hearing Systems
- 10.3.2.3. Auditory Brainstem Implants
- 10.3.3. Orthopedic Bionics
- 10.3.3.1. Upper Limb
- 10.3.3.2. Lower Limb
- 10.3.3.3. Exoskeleton
- 10.3.3.4. Electrical Bone Growth Stimulators
- 10.3.4. Cardiac Bionics
- 10.3.4.1. Pacemaker
- 10.3.4.2. Ventricular Assist Device
- 10.3.4.3. Artificial Heart Valves
- 10.3.5. Neural Bionics
- 10.3.5.1. Internal Neurostimulators
- 10.3.5.2. External Neurostimulators
- 10.4.1. Hospitals
- 10.4.2. Ambulatory Surgical Centers
- 10.4.3. Others
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Baxter International Inc.
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Cochlear Ltd
- 11.6. Edwards Lifesciences Corporation
- 11.7. Heartware International Inc
- 11.8. Abbott Laboratories
- 11.9. Abiomed, Inc.
- 11.10. Asahi Kasei Corporation
- 11.11. Boston Scientific Corporation,
- 11.12. Jarvik Heart, Inc.
- 11.13. Medtronic Plc.
- 11.14. Össur Americas, Inc.
- 11.15. Second Sight Medical Products, Inc.
- 11.16. SynCardia Systems LLC.
- 11.17. Getinge AB
- 11.18. LivaNova PLC
- 11.19. Fresenius Medical Care AG & Co. KGaA
- 11.20. Heartware International Inc.
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
